Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimolegin for VTE Prevention in Knee Replacement
NCT05189002Phase 2Unknown
- Sponsor
- PharmaDiall LLC
- Start
- May 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dimolegin in venous thromboembolism (VTE), sponsored by PharmaDiall LLC. Status: unknown.
02
Drugs
dimolegin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05189002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05189002.